The New York Genome Center and IBM Watson Group Announce Collaboration to Advance Genomic Medicine
Feb 18, 2015 EST
The New York Genome Center (NYGC) and IBM today announced an initiative to accelerate a new era of genomic medicine with the use of IBM's Watson cognitive system. IBM and NYGC will test a unique Watson prototype designed specifically for genomic research as a tool to help oncologists deliver more personalized care to cancer patients.
Like Us on Facebook